AnaptysBio, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 42.21 million compared to USD 26.41 million a year ago. Basic loss per share from continuing operations was USD 1.59 compared to USD 0.93 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.36 USD | -2.30% | -6.60% | +9.06% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.06% | 653M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- AnaptysBio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023